6505--JERRY - Radiopharmaceuticals
VETERANS AFFAIRS, DEPARTMENT OF
Free. Verify your email, then we send one reminder only.
- Posted
- Aug 13, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- 6505--FDG RadiopharmaceuticalSame funderOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- 6505--DaTscanâ„¢ Radioactive Agent for Diagnostic ImagingSame funderOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- 6505--Presolicitation/Sources Sought for Posluma for PET CT ImagingSame funderOpenVETERANS AFFAIRS, DEPARTMENT OFCloses in 7 days
- 6505-- 629-27-1-087-0001 Radiopharmaceutical 5 year (VA-27-00004087) 36C256-26-AP-3959 POC: Veronica MaskellSame funderOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
- Radiopharmaceutical 5 yearSame funderOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
At a glance
This is a government contract opportunity posted by VETERANS AFFAIRS, DEPARTMENT OF in the pharmaceutical preparation manufacturing category.
Classification and identifiers
- Industry (NAICS)
- Pharmaceutical Preparation Manufacturing (325412)
- Product or service (PSC)
- Drugs and Biologicals (6505)
- Solicitation number
- 36C24126Q0738
- Contracting office
- 241-NETWORK CONTRACT OFFICE 01 (36C241)
Who can apply
About this opportunity
The Department of Veterans Affairs, Networking Contracting Office (NCO 01) located in West Haven, CT, intends to enter into a sole source procurement with Novartis Pharmaceuticals Corporation for Lu-177 vipivotide tetraxetan (PLUVICTO). Authority: FAR 8.405-6(a)(1)(i) (items peculiar to one manufacturer), FAR 8.405-6(b) (limited-sources justification), MAS ordering authorities at 41 U.S.C. 152(3) and 40 U.S.C. 501, and GSAM/R 538.7104-3(b) as implemented for MAS sole-source justifications (RFO 8.4). STATEMENT OF WORK RADIOPHARMACEUTICALS Lu-177 vipivotide tetraxetan (PLUVICTO) is a radioligand therapeutic agent to perform the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive and metastatic castration-resistant prostate cancer (mCRPC) who have been treated ...
Related opportunities
- 6505--FDG RadiopharmaceuticalSame funderVETERANS AFFAIRS, DEPARTMENT OF
- 6505--DaTscanâ„¢ Radioactive Agent for Diagnostic ImagingSame funderVETERANS AFFAIRS, DEPARTMENT OF
- 6505--Presolicitation/Sources Sought for Posluma for PET CT ImagingSame funderVETERANS AFFAIRS, DEPARTMENT OFCloses in 7 days
- 6505-- 629-27-1-087-0001 Radiopharmaceutical 5 year (VA-27-00004087) 36C256-26-AP-3959 POC: Veronica MaskellSame funderVETERANS AFFAIRS, DEPARTMENT OF
- Radiopharmaceutical 5 yearSame funderVETERANS AFFAIRS, DEPARTMENT OF
- AN41--523-26-4-1865-0151: 10X Xenium Analyzer Recertification and PM (VA-26-00073846)Same funderVETERANS AFFAIRS, DEPARTMENT OF